Global Biosimulation Market Opportunities and Forecast 2023-2030
- DLR2430
- 30 April, 2022
- Pharma & Healthcare
- Pages: 120
- Global
Global Biosimulation Market, By Offering Type (software, services), By Application (Drug Discovery, Drug Development, Others), By End User (Contract Research Organization, Pharmaceutical & Biotechnology Companies, Research Institutes, Regulatory Institutes, Others), and opportunities and forecast 2023-2030
Biosimulation Market Overview
Biosimulation is a computer-aided mathematical simulation of biological processes and systems and thus is an integral part of systems biology. The global Biosimulation market is expected to witness significant growth in the next few years. This growth is due to technological innovations and research activities in various sides of the medical sector. Additionally, the development of new drugs for various medical diseases and conditions has been occurring in the past few years which raises the demand for biosimulation. This key fact probably drives the growth of the biosimulation market during the forecast period.
Moreover, presently drug development companies and researchers are mainly focusing to find the most effective way to bridge the gap between clinical medicine & drug development and patient response. Also, progressions in software technology and the arrival of artificial intelligence are expected to create a positive influence on the overall growth of the global biosimulation market in the coming years.
On the other hand, factors such as a lack of standardization in biosimulation and the shortage of skilled experts are hampering the growth of the global biosimulation market. In addition, biosimulation uses a variety of models, tools, and languages for processing and capturing many different features of biological processes. Also, the bodies governing it are yet to standardize the use of biosimulation technologies in the process of drug development and discovery. This fact will be creating new opportunities for market development in the coming years.
Biosimulation Market Segment Overview
Based on offering type, the software segment is expected to account for the largest market share in the market. This can be attributed to the increasing adoption of biosimulation software by pharmaceutical and research organizations and the growing R&D investment for pharmaceutical research. Furthermore, the Drug Discovery segment is the fastest-growing segment in the market. Increasing usage of biosimulation and modeling technologies in drug discovery can be attributed to an upsurge in the usage of molecular modeling for the identification of effective compounds that help to improve efficiency and reduce drug toxicity. Moreover, the role of molecular dynamics simulation in drug discovery propels the segment.
Biosimulation Market Regional Overview
North America commanded a major share of the market and is predictable to maintain its supremacy over the forecast period. This is due to increasing collaborations by key players for improving drug discovery capabilities, rising R&D investment by pharmaceutical and biotechnology companies, and growing use of personalized medicines in this region. Similarly, Asia Pacific is expected to expand with an impressive CAGR over the forecast period. The growth of the market in the region can be attributed to the significant demand for innovative drugs, increasing the number of regulatory agencies adopting biosimulation, and rising research activities for life sciences, due to favorable government policies.
Biosimulation Market Competitor overview
· In June 2020, Certara®, the global leader in biosimulation, announced the launch of version 8.3 of its Phoenix™ platform, the industry gold standard in pharmacokinetic/ pharmacodynamic (PK/PD) and toxicokinetic modeling and simulation software. Version 8.3 delivers new features to drive efficiencies and quality and save valuable time.
· In August 2020, Certara®, the global leader in biosimulation, announced the development of a new biosimulation platform for COVID-19 vaccines and major enhancements in its Immunogenicity and Immuno-oncology QSP platforms. Certara has partnered with leading, global pharmaceutical companies on these advancements to help de-risk and speed up drug discovery and development.
Biosimulation Market, Key Players
· Certara, Dassault Systèmes S.A.
· Schrödinger, Inc.
· Simulations Plus, Inc.
· Rhenovia Pharma
· Advanced Chemistry Development, Inc.
· Insilico Biotechnology AG
· Physiomics plc
· Genedata AG
· Rosa & Co. LLC.
Biosimulation Market Segmentation
Biosimulation Market, By Offering Type
· Contract Research Organization
· Pharmaceutical & Biotechnology Companies
· Research Institutes
· Regulatory Institutes
· Others
Biosimulation Market, By Region
Biosimulation Market Overview
Biosimulation is a computer-aided mathematical simulation of biological processes and systems and thus is an integral part of systems biology. The global Biosimulation market is expected to witness significant growth in the next few years. This growth is due to technological innovations and research activities in various sides of the medical sector. Additionally, the development of new drugs for various medical diseases and conditions has been occurring in the past few years which raises the demand for biosimulation. This key fact probably drives the growth of the biosimulation market during the forecast period.
Moreover, presently drug development companies and researchers are mainly focusing to find the most effective way to bridge the gap between clinical medicine & drug development and patient response. Also, progressions in software technology and the arrival of artificial intelligence are expected to create a positive influence on the overall growth of the global biosimulation market in the coming years.
On the other hand, factors such as a lack of standardization in biosimulation and the shortage of skilled experts are hampering the growth of the global biosimulation market. In addition, biosimulation uses a variety of models, tools, and languages for processing and capturing many different features of biological processes. Also, the bodies governing it are yet to standardize the use of biosimulation technologies in the process of drug development and discovery. This fact will be creating new opportunities for market development in the coming years.
Biosimulation Market Segment Overview
Based on offering type, the software segment is expected to account for the largest market share in the market. This can be attributed to the increasing adoption of biosimulation software by pharmaceutical and research organizations and the growing R&D investment for pharmaceutical research. Furthermore, the Drug Discovery segment is the fastest-growing segment in the market. Increasing usage of biosimulation and modeling technologies in drug discovery can be attributed to an upsurge in the usage of molecular modeling for the identification of effective compounds that help to improve efficiency and reduce drug toxicity. Moreover, the role of molecular dynamics simulation in drug discovery propels the segment.
Biosimulation Market Regional Overview
North America commanded a major share of the market and is predictable to maintain its supremacy over the forecast period. This is due to increasing collaborations by key players for improving drug discovery capabilities, rising R&D investment by pharmaceutical and biotechnology companies, and growing use of personalized medicines in this region. Similarly, Asia Pacific is expected to expand with an impressive CAGR over the forecast period. The growth of the market in the region can be attributed to the significant demand for innovative drugs, increasing the number of regulatory agencies adopting biosimulation, and rising research activities for life sciences, due to favorable government policies.
Biosimulation Market Competitor overview
· In June 2020, Certara®, the global leader in biosimulation, announced the launch of version 8.3 of its Phoenix™ platform, the industry gold standard in pharmacokinetic/ pharmacodynamic (PK/PD) and toxicokinetic modeling and simulation software. Version 8.3 delivers new features to drive efficiencies and quality and save valuable time.
· In August 2020, Certara®, the global leader in biosimulation, announced the development of a new biosimulation platform for COVID-19 vaccines and major enhancements in its Immunogenicity and Immuno-oncology QSP platforms. Certara has partnered with leading, global pharmaceutical companies on these advancements to help de-risk and speed up drug discovery and development.
Biosimulation Market, Key Players
· Certara, Dassault Systèmes S.A.
· Schrödinger, Inc.
· Simulations Plus, Inc.
· Rhenovia Pharma
· Advanced Chemistry Development, Inc.
· Insilico Biotechnology AG
· Physiomics plc
· Genedata AG
· Rosa & Co. LLC.
Biosimulation Market Segmentation
Biosimulation Market, By Offering Type
- software
- PK/PD modeling & simulation
- PBPK modeling & simulation
- Trial Simulators
- Molecular Modeling
- Others
- services
- Drug Discovery
- Target Identification & Validation
- Lead Identification & Optimization
- Drug Development
- Pre-Clinical Testing
- Clinical Trial
- Others
· Contract Research Organization
· Pharmaceutical & Biotechnology Companies
· Research Institutes
· Regulatory Institutes
· Others
Biosimulation Market, By Region
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Biosimulation Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Offering Type
- 5.2.1. software
- 5.2.1.1. PK/PD modeling & simulation
- 5.2.1.2. PBPK modeling & simulation
- 5.2.1.3. Trial Simulators
- 5.2.1.4. Molecular Modeling
- 5.2.1.5. Others
- 5.2.2. services
- 5.2.1. software
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Drug Discovery
- 5.3.1.1. Target Identification & Validation
- 5.3.1.2. Lead Identification & Optimization
- 5.3.2. Drug Development
- 5.3.2.1. Pre-Clinical Testing
- 5.3.2.2. Clinical Trial
- 5.3.3. Others
- 5.3.1. Drug Discovery
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Contract Research Organization
- 5.4.2. Pharmaceutical & Biotechnology Companies
- 5.4.3. Research Institutes
- 5.4.4. Regulatory Institutes
- 5.4.5. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Latin America
- 5.5.3. Europe
- 5.5.4. Asia Pacific
- 5.5.5. Middle East and Africa
6. North America Biosimulation Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Offering Type
- 6.2.1. software
- 6.2.1.1. PK/PD modeling & simulation
- 6.2.1.2. PBPK modeling & simulation
- 6.2.1.3. Trial Simulators
- 6.2.1.4. Molecular Modeling
- 6.2.1.5. Others
- 6.2.2. services
- 6.2.1. software
- 6.3. Market Analysis, Insights and Forecast – By Application
- 6.3.1. Drug Discovery
- 6.3.1.1. Target Identification & Validation
- 6.3.1.2. Lead Identification & Optimization
- 6.3.2. Drug Development
- 6.3.2.1. Pre-Clinical Testing
- 6.3.2.2. Clinical Trial
- 6.3.3. Others
- 6.3.1. Drug Discovery
- 6.4. Market Analysis, Insights and Forecast – By End User
- 6.4.1. Contract Research Organization
- 6.4.2. Pharmaceutical & Biotechnology Companies
- 6.4.3. Research Institutes
- 6.4.4. Regulatory Institutes
- 6.4.5. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Latin America Biosimulation Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Offering Type
- 7.2.1. software
- 7.2.1.1. PK/PD modeling & simulation
- 7.2.1.2. PBPK modeling & simulation
- 7.2.1.3. Trial Simulators
- 7.2.1.4. Molecular Modeling
- 7.2.1.5. Others
- 7.2.2. services
- 7.2.1. software
- 7.3. Market Analysis, Insights and Forecast – By Application
- 7.3.1. Drug Discovery
- 7.3.1.1. Target Identification & Validation
- 7.3.1.2. Lead Identification & Optimization
- 7.3.2. Drug Development
- 7.3.2.1. Pre-Clinical Testing
- 7.3.2.2. Clinical Trial
- 7.3.3. Others
- 7.3.1. Drug Discovery
- 7.4. Market Analysis, Insights and Forecast – By End User
- 7.4.1. Contract Research Organization
- 7.4.2. Pharmaceutical & Biotechnology Companies
- 7.4.3. Research Institutes
- 7.4.4. Regulatory Institutes
- 7.4.5. Others
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. Brazil
- 7.5.2. Mexico
- 7.5.3. Rest of Latin America
8. Europe Biosimulation Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Offering Type
- 8.2.1. software
- 8.2.1.1. PK/PD modeling & simulation
- 8.2.1.2. PBPK modeling & simulation
- 8.2.1.3. Trial Simulators
- 8.2.1.4. Molecular Modeling
- 8.2.1.5. Others
- 8.2.2. services
- 8.2.1. software
- 8.3. Market Analysis, Insights and Forecast – By Application
- 8.3.1. Drug Discovery
- 8.3.1.1. Target Identification & Validation
- 8.3.1.2. Lead Identification & Optimization
- 8.3.2. Drug Development
- 8.3.2.1. Pre-Clinical Testing
- 8.3.2.2. Clinical Trial
- 8.3.3. Others
- 8.3.1. Drug Discovery
- 8.4. Market Analysis, Insights and Forecast – By End User
- 8.4.1. Contract Research Organization
- 8.4.2. Pharmaceutical & Biotechnology Companies
- 8.4.3. Research Institutes
- 8.4.4. Regulatory Institutes
- 8.4.5. Others
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. UK
- 8.5.2. Germany
- 8.5.3. France
- 8.5.4. Italy
- 8.5.5. Spain
- 8.5.6. Russia
- 8.5.7. Rest of Europe
9. Asia Pacific Biosimulation Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Offering Type
- 9.2.1. software
- 9.2.1.1. PK/PD modeling & simulation
- 9.2.1.2. PBPK modeling & simulation
- 9.2.1.3. Trial Simulators
- 9.2.1.4. Molecular Modeling
- 9.2.1.5. Others
- 9.2.2. services
- 9.2.1. software
- 9.3. Market Analysis, Insights and Forecast – By Application
- 9.3.1. Drug Discovery
- 9.3.1.1. Target Identification & Validation
- 9.3.1.2. Lead Identification & Optimization
- 9.3.2. Drug Development
- 9.3.2.1. Pre-Clinical Testing
- 9.3.2.2. Clinical Trial
- 9.3.3. Others
- 9.3.1. Drug Discovery
- 9.4. Market Analysis, Insights and Forecast – By End User
- 9.4.1. Contract Research Organization
- 9.4.2. Pharmaceutical & Biotechnology Companies
- 9.4.3. Research Institutes
- 9.4.4. Regulatory Institutes
- 9.4.5. Others
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. China
- 9.5.2. India
- 9.5.3. Japan
- 9.5.4. Australia
- 9.5.5. South East Asia
- 9.5.6. Rest of Asia Pacific
10. Middle East & Africa Biosimulation Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Offering Type
- 10.2.1. software
- 10.2.1.1. PK/PD modeling & simulation
- 10.2.1.2. PBPK modeling & simulation
- 10.2.1.3. Trial Simulators
- 10.2.1.4. Molecular Modeling
- 10.2.1.5. Others
- 10.2.2. services
- 10.2.1. software
- 10.3. Market Analysis, Insights and Forecast – By Application
- 10.3.1. Drug Discovery
- 10.3.1.1. Target Identification & Validation
- 10.3.1.2. Lead Identification & Optimization
- 10.3.2. Drug Development
- 10.3.2.1. Pre-Clinical Testing
- 10.3.2.2. Clinical Trial
- 10.3.3. Others
- 10.3.1. Drug Discovery
- 10.4. Market Analysis, Insights and Forecast – By End User
- 10.4.1. Contract Research Organization
- 10.4.2. Pharmaceutical & Biotechnology Companies
- 10.4.3. Research Institutes
- 10.4.4. Regulatory Institutes
- 10.4.5. Others
- 10.5. Market Analysis, Insights and Forecast – By Country
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2018
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.4. Certara, Dassault Systèmes S.A.
- 11.4.1. Business Overview
- 11.4.2. Segment 1 & Service Offering
- 11.4.3. Overall Revenue
- 11.4.4. Geographic Presence
- 11.4.5. Recent Development
- 11.5. Schrödinger, Inc.
- 11.6. Simulations Plus, Inc.
- 11.7. Rhenovia Pharma
- 11.8. Advanced Chemistry Development, Inc.
- 11.9. Insilico Biotechnology AG
- 11.10. Physiomics plc
- 11.11. Genedata AG
List of Figures
Figure 1: Global Biosimulation Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Biosimulation Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Biosimulation Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Biosimulation Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Biosimulation Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Biosimulation Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Biosimulation Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Biosimulation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Biosimulation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Biosimulation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Biosimulation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Biosimulation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Biosimulation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Figure 1: Global Biosimulation Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
Figure 2: Global Market Value Share (%), By Segment 1, 2019 & 2027
Figure 3: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 4: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 5: Global Market Value Share (%), By Segment 2, 2019 & 2027
Figure 6: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 7: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 8: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 9: Global Biosimulation Market Forecast (USD Billion), by Others, 2016-2027
Figure 10: Global Market Value Share (%), By Segment 3, 2019 & 2027
Figure 11: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 12: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 13: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 14: Global Market Forecast (USD Billion), by Others, 2016-2027
Figure 15: Global Market Value (USD Billion), by Region, 2019 & 2027
Figure 16: North America Biosimulation Market Value Share (%), By Segment 1, 2019 & 2027
Figure 17: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 18: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 19: North America Market Value Share (%), By Segment 2, 2019 & 2027
Figure 20: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 21: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 22: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 23: North America Market Forecast (USD Billion), by Others, 2016-2027
Figure 24: North America Market Value Share (%), By Segment 3, 2019 & 2027
Figure 25: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 26: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 27: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 28: North America Market Forecast (USD Billion), by Others, 2016-2027
Figure 29: North America Market Forecast (USD Billion), by U.S., 2016-2027
Figure 30: North America Market Forecast (USD Billion), by Canada, 2016-2027
Figure 31: Latin America Biosimulation Market Value Share (%), By Segment 1, 2019 & 2027
Figure 32: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 33: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 34: Latin America Market Value Share (%), By Segment 2, 2019 & 2027
Figure 35: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 36: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 37: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 38: Latin America Market Forecast (USD Billion), by Others, 2016-2027
Figure 39: Latin America Market Value Share (%), By Segment 3, 2019 & 2027
Figure 40: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 41: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 42: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 43: Latin America Market Forecast (USD Billion), by Others, 2016-2027
Figure 44: Latin America Market Forecast (USD Billion), by Brazil, 2016-2027
Figure 45: Latin America Market Forecast (USD Billion), by Mexico, 2016-2027
Figure 46: Latin America Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
Figure 47: Europe Biosimulation Market Value Share (%), By Segment 1, 2019 & 2027
Figure 48: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 49: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 50: Europe Market Value Share (%), By Segment 2, 2019 & 2027
Figure 51: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 52: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 53: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 54: Europe Market Forecast (USD Billion), by Others, 2016-2027
Figure 55: Europe Market Value Share (%), By Segment 3, 2019 & 2027
Figure 56: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 57: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 58: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 59: Europe Market Forecast (USD Billion), by Others, 2016-2027
Figure 60: Europe Market Forecast (USD Billion), by U.K., 2016-2027
Figure 61: Europe Market Forecast (USD Billion), by Germany, 2016-2027
Figure 62: Europe Market Forecast (USD Billion), by France, 2016-2027
Figure 63: Europe Market Forecast (USD Billion), by Italy, 2016-2027
Figure 64: Europe Market Forecast (USD Billion), by Spain, 2016-2027
Figure 65: Europe Market Forecast (USD Billion), by Russia, 2016-2027
Figure 66: Europe Market Forecast (USD Billion), by Rest of Europe, 2016-2027
Figure 67: Asia Pacific Biosimulation Market Value Share (%), By Segment 1, 2019 & 2027
Figure 68: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 69: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 70: Asia Pacific Market Value Share (%), By Segment 2, 2019 & 2027
Figure 71: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 72: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 73: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 74: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
Figure 75: Asia Pacific Market Value Share (%), By Segment 3, 2019 & 2027
Figure 76: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 77: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 78: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 79: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
Figure 80: Asia Pacific Market Forecast (USD Billion), by China, 2016-2027
Figure 81: Asia Pacific Market Forecast (USD Billion), by India, 2016-2027
Figure 82: Asia Pacific Market Forecast (USD Billion), by Japan, 2016-2027
Figure 83: Asia Pacific Market Forecast (USD Billion), by Australia, 2016-2027
Figure 84: Asia Pacific Market Forecast (USD Billion), by Southeast Asia, 2016-2027
Figure 85: Asia Pacific Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
Figure 86: Middle East & Africa Biosimulation Market Value Share (%), By Segment 1, 2019 & 2027
Figure 87: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 88: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 89: Middle East & Africa Market Value Share (%), By Segment 2, 2019 & 2027
Figure 90: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 91: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 92: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 93: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
Figure 94: Middle East & Africa Market Value Share (%), By Segment 3, 2019 & 2027
Figure 95: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
Figure 96: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
Figure 97: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
Figure 98: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
Figure 99: Middle East & Africa Market Forecast (USD Billion), by GCC, 2016-2027
Figure 100: Middle East & Africa Market Forecast (USD Billion), by South Africa, 2016-2027
Figure 101: Middle East & Africa Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027
List of Tables
Table 1: Global Biosimulation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 2: Global Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 3: Global Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 4: Global Market Revenue (USD Billion) Forecast, by Region, 2016-2027
Table 5: North America Biosimulation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 6: North America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 7: North America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 8: North America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 9: Europe Biosimulation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 10: Europe Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 11: Europe Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 12: Europe Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 13: Latin America Biosimulation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 14: Latin America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 15: Latin America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 16: Latin America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 17: Asia Pacific Biosimulation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 18: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 19: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 20: Asia Pacific Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Table 21: Middle East & Africa Biosimulation Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
Table 22: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
Table 23: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
Table 24: Middle East & Africa Market Revenue (USD Billion) Forecast, by Country, 2016-2027
Report You Might be Interested
Choose License Type
- USD
- GBP
- EURO
- INR
